---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-266938"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2025-11-05T23:59:59+00:00"
generated_at: "2026-05-17T00:10:48.753096+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# RxSight Q3 revenue down 14% YoY to $30.3M; net loss widens to $9.8M

## Summary
- Revenue $30.3M (-14% YoY); LAL volume up 6% but LDD placements down 68%.
- Net loss $(9.8)M ($(0.24)/share) vs $(6.3)M ($(0.16)/share) in Q3 2024.
- Adjusted net loss $(1.7)M ($(0.04)/share) vs adjusted net gain $0.2M prior year.
- Narrowed FY2025 revenue guidance to $125-130M (prior $120-130M); raised gross margin guidance to 76-77%.
- Cash and investments $227.5M, unchanged from June 30, 2025.

## SEC filing metadata
- accession: 0001193125-25-266938
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2025-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000119312525266938/0001193125-25-266938-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000119312525266938/rxst-20251105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-266938
- JSON: https://secwatch.observer/filing/0001193125-25-266938.json
- Plain text: https://secwatch.observer/filing/0001193125-25-266938.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.